NASDAQ:APM
Aptorum Group Limited Class A Stock News
$5.10
+0.400 (+8.51%)
At Close: May 16, 2024
Az Aptorum Group Limited (a továbbiakban
アプトラム・グループがナガイモ由来の生理活性ニュートラシューティカルズ錠の商業化を開始し、香港における販売契約を締結
10:31am, Tuesday, 25'th Feb 2020
（ビジネスワイヤ） -- 世界規模の未充足医療ニーズに対処するための新規治療薬の開発に傾注する製薬企業の知臨集団（アプトラム・グループ）は�
知臨集團開始商品化山藥生物活性營養片劑並在香港簽署銷售經銷協議
04:15am, Tuesday, 25'th Feb 2020
(美國商業資訊)--致力於開發創新療法以解決全球未被滿足的醫療需求的生物製藥公司知臨集團（那斯達克股票代碼：APM），公布商品化其膳食補充劑，�
Aptorum Group Limited („Aptorum Group”), firma farmaceutyczna opracowująca nowe terapie, które odpowiadają na światowe problemy medyczne, ogłosiła wpr
NEW YORK — Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the …
Aptorum Group Limited ("Aptorum Group"), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the commercialization of its dietary
Gen Z is Leading the Way to Alternative Payment Options
08:00pm, Thursday, 20'th Feb 2020
Millennials are often seen as the most digitally savvy generation, but they were actually raised during a time when the
apM Coin Price, News and Analysis (APM)
06:51am, Thursday, 20'th Feb 2020
Are you thinking about adding apM Coin (APM) to your cryptocurrency portfolio? View APM's latest price, chart, headlines, social sentiment, price prediction and more at MarketBeat.
Az Aptorum Group Limited (Nasdaq: APM) (a továbbiakban
Az Aptorum Csoport további előrelépésről számolt be a Staphylococcus aureus által okozott fertőzéseknek egy virulenciagátláson alapuló, nem baktericid
知臨集團宣布用於神經母細胞瘤的再利用候選藥物SACT-1取得顯著進展並計畫2020下半年提交IND
01:03am, Tuesday, 11'th Feb 2020
(美國商業資訊)--致力於開發創新療法以解決全球未被滿足的醫療需求的生物製藥公司知臨集團（那斯達克股票代碼：APM），宣布其再利用候選藥物SACT-1�
知臨集團宣布其用於治療由金黃色葡萄球菌所引起的感染的ALS-4小分子抗毒力（非殺菌）候選藥物的進一步正面資料，並可望於2020年下半年提交IND
12:48am, Tuesday, 11'th Feb 2020
(美國商業資訊)--致力於開發創新療法以解決全球未被滿足的醫療需求的生物製藥公司知臨集團（那斯達克股票代碼：APM），公布其正進行的ALS-4試驗用�
NEW YORK — Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical need…
NEW YORK — Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical need…
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and d
